InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Freund John Gordon, Director. Insider active across 3 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 17 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €3.6m. History available since 20 May 2021. The latest transaction was disclosed on 8 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Freund John Gordon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
11,659 shares@ US$34.363266.0% of flowCommon StockSEC:0001062993-25-014202:0
12,132 shares@ US$15.99065.2% of flowCommon StockSEC:0001562180-25-005706:0
15,000 shares@ US$13.45100.0% of flowCommon StockSEC:0001062993-25-011425:0
8,675 shares0Common StockSEC:0001562180-25-004608:0
9,791 shares0Common StockSEC:0001062993-25-009806:0
8,791 shares0Common StockSEC:0001562180-24-005334:0
7,693 shares0Common StockSEC:0001062993-24-010540:0
30,000 shares@ US$20.539910.1% of flowCommon StockSEC:0001562180-23-006298:0
4,866 shares0Common StockSEC:0001562180-23-005109:0
9,792 shares0Common StockSEC:0001062993-23-011817:0
8,324 shares0Common StockSEC:0001562180-22-005236:0
14,035 shares0Common StockSEC:0001062993-22-013302:0
17,990 shares@ US$31.280614.4% of flowCommon StockSEC:0001562180-21-004319:0
3,848 shares0Common StockSEC:0001562180-21-004257:0
26,367 shares@ US$30.929720.8% of flowCommon StockSEC:0001562180-21-003880:0
50,827 shares@ US$32.540942.1% of flowCommon StockSEC:0001562180-21-003755:0
9,941 shares0Common StockSEC:0001192482-21-000460:0
17 of 17 declarations
About Freund John Gordon
Freund John Gordon is Administrateur at SI-BONE, Inc. and Collegium Pharmaceutical, INC, and he was also reported as Director at COLLEGIUM PHARMACEUTICAL, INC. The 17 available filings, all of which are included in the sampled set, cover the period from 2021-05-24 to 2025-08-12, with 0 in purchases and 3557705 in sales, and the largest filings include sales at SI-BONE, Inc. on 2021-05-26 for 1354077.495825849, on 2021-06-01 for 668835.217966624, on 2023-08-11 for 561318.5089830986 and on 2021-06-16 for 464219.4733907477, as well as a sale at Collegium Pharmaceutical, INC on 2025-08-12 for 343112.57798855.
